Roche acquires mySugr to form a digital diabetes management platform
The idea is to make mySugr an integral part of Roche's new patient-centered digital health services platform in diabetes care.
Livongo Health raises $52.5M accelerate growth in diabetes management
The company will use the funds to expand to other chronic conditions, and move to international markets.
Livongo, Voluntis launch an integrated app for diabetes management
Under the deal, the Livongo for Diabetes program will be offered with Voluntis' Insulia, an FDA-cleared medical device and app.
Roche, mySugr to further broaden access to digital health solutions for diabetics
Users will benefit from enhanced capabilities to share diabetes data with their healthcare providers and caregivers.
GluSense gets funding for its implantable biosensor that could provide a year-long CGM
The company will use the money to continue development of Glyde, a long-term injectable glucose sensor.
Blue Shield of CA, Solera Health team-up for diabetes prevention
Now, members will have access to Solera's nationwide network of Diabetes Prevention Programs (DPP) as a covered medical benefit.
Glooko, Ascensia team-up to improve diabetes management
Ascensia Diabetes Care and Glooko teamed-up to bring together their state-of-the-art diabetes management solutions.
Bigfoot Biomedical raises money for its smart insulin delivery system
The money will be used to further develop Bigfoot's automated insulin delivery service called smartloop.
Common Sensing, Welkin Health team-up to develop an insulin adherence program
The program will combine insulin dosing data, real-time blood glucose data, and data from Welkin Health coaches to support patients in their daily lives.
Non-prescription version of WellDoc’s BlueStar Digital Therapeutic gets FDA 510(k) clearance
The non-prescription version will have all the first-in-class features of BlueStar® Rx apart from an insulin calculator.